CD19 and lung carcinoma: In one study, the levels of CD3+, CD4+, CD4+/CD8+, and CD19+ cells in the peripheral blood of lung cancer patients before radiotherapy were significantly lower than those in healthy controls (p < 0.05) (43), which is consistent with our findings.